By combining NUPR1 and TRIB3 with other clinical characteristics of DLBCL patients, such as gender, age, diagnosis type, stage, LDH ratio, number of extranodal lymph nodes, and ECOG score. This evidence concerns the gene NUPR1 and diffuse large B-cell lymphoma.